# Modular Medical, Inc.: overview MODD · Nasdaq · CIK 1074871 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/modd.md) · [Financials](/companies/modd/financials.md) · [Filings](/companies/modd/filings.md) · [Insiders](/companies/modd/insiders.md) Latest reported revenue: [$0](/filings/0001019056-19-000143.md) for Q3 FY2019, three months to 2018-12-31, from the 10-Q filed Feb 14, 2019 (XBRL us-gaap:Revenues, accession 0001019056-19-000143). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.14)](/filings/0001213900-25-110819.md) | [(0.13)](/filings/0001213900-26-017262.md) | not reported | [(3.70)](/filings/0001213900-26-090301.md) | [(0.14)](/filings/0001213900-25-110819.md) | [(0.11)](/filings/0001213900-26-017262.md) | not reported | [(1.19)](/filings/0001213900-26-090301.md) | | Free cash flow | $k | [(3,927) d](/filings/0001213900-25-110819.md) | [(4,638) d](/filings/0001213900-26-017262.md) | [(5,258) d](/filings/0001213900-26-073223.md) | [(6,306)](/filings/0001213900-26-090301.md) | [(6,182) d](/filings/0001213900-25-110819.md) | [(8,377) d](/filings/0001213900-26-017262.md) | [(6,820) d](/filings/0001213900-26-073223.md) | [(6,660)](/filings/0001213900-26-090301.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(2.74)](/filings/0001213900-23-051688.md) | [(1.15)](/filings/0001213900-24-054877.md) | [(0.78)](/filings/0001213900-25-055793.md) | [(15.26)](/filings/0001213900-26-073223.md) | [(12.36)](/filings/0001213900-26-073223.md) | | Free cash flow | $m | [(10.3)](/filings/0001213900-23-051688.md) | [(12.6)](/filings/0001213900-24-054877.md) | [(15.7)](/filings/0001213900-25-055793.md) | [(18.2)](/filings/0001213900-26-073223.md) | [(27.7)](/filings/0001213900-26-073223.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/modd/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [AWM Investment Company, Inc.](/funds/1535264.md) | 2026-06-30 | $2.0m | 441,095 | | Added +74,429 | | [Solas Capital Management, LLC](/funds/1604867.md) | 2026-06-30 | $2.0m | 438,095 | | Added +150,000 | | [Bleichroeder LP](/funds/1781002.md) | 2026-06-30 | $1.5m | 336,986 | | Added +150,000 | | [683 Capital Management, LLC](/funds/1404574.md) | 2026-06-30 | $585.0k | 130,000 | | Added +4,999 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $464.3k | 103,182 | | Added +47,265 | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $457.8k | 101,744 | | Added +2,254 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $280.5k | 62,331 | | New +62,331 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $236.9k | 52,645 | | Added +25,158 | | [Sio Capital Management, LLC](/funds/1482416.md) | 2026-06-30 | $117.9k | 26,190 | | Unchanged | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $89.2k | 19,825 | | New +19,825 | ## Recent filings [All 578 filings](/companies/modd/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 16:10 ET | [8-K](/filings/0001213900-26-113310.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-26-113310 | | 2026-10-01 | 09:24 ET | [DEF 14A](/filings/0001213900-26-105495.md) | Proxy statement, period 2026-10-23 | 0001213900-26-105495 | | 2026-09-29 | 16:10 ET | [8-K](/filings/0001213900-26-104656.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-104656 | | 2026-09-03 | 17:15 ET | [8-K](/filings/0001213900-26-097280.md) | 5.08 Item not in the standard list | 0001213900-26-097280 | | 2026-08-14 | 17:25 ET | [10-Q](/filings/0001213900-26-090301.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090301 | | 2026-06-29 | 17:24 ET | [10-K](/filings/0001213900-26-073223.md) | Annual report, period 2026-03-31 | 0001213900-26-073223 | | 2026-05-20 | 16:30 ET | [8-K](/filings/0001213900-26-059557.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-059557 | | 2026-04-21 | 12:20 ET | [8-K](/filings/0001213900-26-045985.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-045985 | | 2026-04-16 | 08:30 ET | [8-K](/filings/0001213900-26-044343.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-044343 | | 2026-03-31 | 16:35 ET | [8-K](/filings/0001213900-26-037531.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037531 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001213900-26-073223.md), filed Jun 29, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1074871 - Tickers: MODD - Exchange: Nasdaq - SIC code: 3841 Surgical & Medical Instruments & Apparatus - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:11 ET. No prices; not investment advice.